-
Eluminex Biosciences Announces Phase 1b Single Ascending Dose Study Results of a Novel Pentavalent Trispecific Fusion Antibody (EB-105) in Patients with Diabetic Macular Edema (DME)
-
VivaVision Announces Positive Comments from FDA for the Type C Meeting Regarding VVN461LD for Post-operative Infalmmation – Agreeing the Phase 2 Trial to Be Served as One of the Two Pivotal Studies.
-
Firework Recognized with Frost & Sullivan's 2025 Global Competitive Strategy Leadership Award
-
The Yaber T2 Plus GTV Is Now Available: A More Integrated Entertainment Projector
-
India converts adversity into accomplishment: Afcons builds world's highest single-arch railway bridge, 35m taller than Eiffel Tower, in Himalayan terrain
-
Jackery Presents Latest Sustainable Energy Solutions at AIA25 Expo
-
Generative Video Pioneer Vidu Powers Honor 400 Series & Reimagines Journey to the West to Forge Blueprint for Next-Gen Original AI Studio
-
Nisun International Expands into Edible Oil Trading Sector, Targeting RMB 3 Billion (USD 415 Million) in 2025 Revenue.